Table 1 Characteristics of patients with and without major endpoint
From: Prognostic value of right atrial strains in arrhythmogenic right ventricular cardiomyopathy
No endpoints | Endpoints | p value | |
|---|---|---|---|
Demographics | |||
Age (years) | 44 ± 16 | 42 ± 20 | 0.504 |
Men | 47 (68) | 21 (58) | 0.319 |
Hypertension | 16 (23) | 7 (19) | 0.660 |
Diabetes | 4 (6) | 2 (6) | 0.664 |
Task force criteria | |||
Echocardiographic TF major criterion | 26 (38) | 13 (36) | 0.874 |
Echocardiographic TF minor criterion | 22 (32) | 12 (33) | 0.880 |
RV angiography | 58 (84) | 29 (81) | 0.651 |
ECG major repolarization criterion | 17 (25) | 13 (36) | 0.217 |
ECG minor repolarization criterion | 16 (23) | 9 (25) | 0.836 |
ECG major depolarization criterion | 4 (6) | 2 (6) | 0.664 |
ECG minor depolarization criterion | 32 (46) | 18 (50) | 0.724 |
Arrhythmias major criterion | 19 (28) | 7 (19) | 0.362 |
Arrhythmias minor criterion | 31 (45) | 19 (53) | 0.445 |
Family history | 15 (22) | 9 (25) | 0.706 |
CMR major criterion | 50 (72) | 27 (75) | 0.780 |
CMR minor criterion | 12 (17) | 2 (6) | 0.770 |
Clinical presentation | |||
Recent cardiac syncope | 5 (7) | 8 (22) | 0.027 |
NVST | 28 (41) | 23 (64) | 0.023 |
24-h PVC count | 983 (385–2529) | 2580 (475–4422) | 0.010 |
Leads with anterior and inferior TWI | 2 (1–3) | 3 (2–4) | 0.001 |
5-yr ARVC risk score | 0.22 (0.11–0.38) | 0.35 (0.17–0.72) | 0.012 |
CMR parameters | |||
RVEDVI (mL/m2) | 116.32 (87.21–146.30) | 121.69 (90.49–167.16) | 0.181 |
RVESVI (mL/m2) | 73.78 (51.90–109.57) | 87.94 (69.49–135.55) | 0.037 |
RVEF (%) | 32.89 ± 12.66 | 24.86 ± 11.37 | 0.002 |
RV GLS (%) | - 8.49 (- 11.45 to - 5.94) | - 5.55 (- 8.45 to - 3.74) | 0.003 |
RV GCS (%) | - 6.72 (- 10.96–3.20) | - 4.97 (- 8.71 to - 1.73) | 0.078 |
RV GRS (%) | 19.10 (10.66–30.07) | 12.14 (4.38–20.37) | 0.008 |
RV LGE presence | 47 (68) | 22 (61) | 0.472 |
RV WMA | 57 (83) | 28 (78) | 0.550 |
RV fatty infiltration | 18 (26) | 11 (31) | 0.627 |
RAEDVI (mL/m2) | 43.58 (33.59–59.12) | 43.44 (30.47–95.90) | 0.466 |
RAESVI (mL/m2) | 21.07 (15.76–30.93) | 24.64 (16.95–50.91) | 0.142 |
RAEF (%) | 49.63 (44.78–55.95) | 45.51 (40.89–49.51) | 0.009 |
RA reservoir strain (%) | 27.10 (24.00–36.75) | 24.20 (11.88–27.50) | 0.001 |
RA conduit strain (%) | 14.20 (9.15–19.35) | 11.55 (6.18–13.58) | 0.004 |
RA booster strain (%) | 14.00 (11.35–16.70) | 10.45 (5.05–14.18) | < 0.001 |
RA reservoir strain rate (sec-1) | 1.60 (1.10–1.95) | 1.10 (0.73~1.50) | < 0.001 |
RA conduit strain rate (sec-1) | - 0.90 (- 1.35 to - 0.70) | - 0.65 (- 0.80 to - 0.43) | < 0.001 |
RA booster strain rate (sec-1) | - 1.60 (- 1.90 to - 1.20) | - 1.30 (- 1.60 to - 0.80) | 0.007 |
LV involvement analysis | |||
LVEF (%) | 58.80 (50.35–61.94) | 32.07 (22.44–39.31) | < 0.001 |
LV LGE presence | 33 (48) | 29 (81) | 0.001 |
LV WMA | 20 (29) | 26 (72) | < 0.001 |
LV fatty infiltration | 27 (39) | 23 (64) | 0.016 |
LV Involvement | 34 (49) | 29 (81) | 0.002 |